Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2024 Earnings Call Transcript February 27, 2025
Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.89.
Operator: Hello and thank you for standing by. At this time, I would like to welcome you to the Q4 2024 Xenon Pharmaceuticals, Inc. Earnings Conference Call. All lines has been placed in mute, to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer...
